BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1837333)

  • 1. Purine metabolism enzyme pattern, cytochemical characteristics and clinicopathologic features of CD10-positive childhood T-cell leukemia.
    Babusíková O; Cáp J; Hrivnáková A; Klobusická M; Mesárosová A; Koníková E
    Neoplasma; 1991; 38(6):595-602. PubMed ID: 1837333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
    Babusíková O; Hrivnáková A; Cáp J; Ujházy P
    Neoplasma; 1988; 35(6):683-90. PubMed ID: 2975765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
    Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
    Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential prognosis detected by immunophenotyping in acute lymphoblastic leukemia of childhood with poor prognostic factors.
    Hirata R; Horibe K; Matsuoka H; Ueda R; Iwamura H
    Jpn J Clin Oncol; 1987 Sep; 17(3):229-35. PubMed ID: 2959808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
    Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
    Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymes of purine metabolism and membrane phenotype in malignant cells of some leukemia patients.
    Babusíková O; Hrivnáková A; Pechán I; Ujházy P
    Neoplasma; 1984; 31(6):661-6. PubMed ID: 6441124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinical picture (event free survival and overall survival) in childhood acute leukemia patients with immunophenotype and chromosomal abnormalities.
    Babusíková O; Sejnová D; Kirschnerová G; Kirsnerová Z; Cáp J
    Neoplasma; 2000; 47(6):382-9. PubMed ID: 11263863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
    Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
    Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
    Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Leukemia; 1992 May; 6(5):375-80. PubMed ID: 1593902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
    Gobbi G; Mirandola P; Malinverno C; Sponzilli I; Carubbi C; Ricci F; Binazzi R; Basso G; Giuliani-Piccari G; Ramazzotti G; Pasquantonio G; Cocco L; Vitale M
    Int J Oncol; 2008 Aug; 33(2):371-4. PubMed ID: 18636158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
    Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
    Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.